gemcitabine
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
3 FDA-registered drug labelers
Janssen Biotech, Inc
ScinoPharm Taiwan Ltd.
Zhejiang Hisun Pharmaceutical Co., Ltd.
Why It Matters
Sectors
Health
Downstream Uses
Appears in 1 drug and cosmetic product listings (FDA).
- •Inlexzo
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No Shortage
Shortage History
Each row is a separate manufacturer's FDA shortage filing — not a timeline for the drug as a whole. Multiple "current" entries are normal: each manufacturer/NDC files independently. Status reflects the manufacturer's report; reason describes their supply situation (Available, Unavailable, or to be discontinued).
to be discontinued
Gemcitabine Hydrochloride Injection
09/11/2025Chemical Identity
CAS95058-81-4
PubChem CID60750
DTXSIDDTXSID3040487
FormulaC9H11F2N3O4
Mol. Weight263.2 g/mol
SMILESC1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
Data Sources
607502026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/gemcitabine/cids/JSON
Archive: data/sources/pubchem_name/gemcitabine.json
CAS 95058-81-42026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
CAS 95058-81-42026-06-13
https://api.fda.gov/drug/shortages.json
Archive: data/sources/fda/shortages/shortages.json